TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
-10.71%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$286M
AUM Growth
–
Cap. Flow
+$286M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Voyager Therapeutics
VYGR
|
$156M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$63M |
| 3 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
$38.9M |
| 4 |
Editas Medicine
EDIT
|
$27.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Voyager Therapeutics
VYGR
$186M
| $156M | 54.58% |
+9,391,176
| New | +$156M |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $63M | 22.06% |
+1,496,598
| New | +$63M |
|
|
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $38.9M | 13.61% |
+3,048,780
| New | +$38.9M |
|
|
4
Editas Medicine
EDIT
$231M
| $27.8M | 9.75% |
+906,176
| New | +$27.8M |
|